Vernino Lab focuses on the mechanisms of autoimmune disorders of the nervous system. We use a variety of techniques including animal physiology, cellular electrophysiology, histology, and immunology.
The immune system plays a primary role in many serious diseases of the nervous system including multiple sclerosis, myasthenia gravis, and paraneoplastic neurologic disorders. These autoimmune disorders are important because they are potentially treatable but may be undiagnosed or frequently misdiagnosed as another untreatable condition. Over the past 10 years, new laboratory (antibody) tests have been developed to help identify autoimmune neurological disorders and many clinical syndromes have been described. This is a growing and exciting area of clinical neurology.
Our lab has a particular interest in diseases associated with antibodies against ion channels. Voltage and ligand-gated ion channels allow nerve cells to have their unique electrical properties, and such antibodies could directly change how nerve cells function. Antibodies against the acetylcholine receptor on muscle are the cause of myasthenia gravis. Recent work in the laboratory has shown that antibodies against acetylcholine receptors on certain neurons are the cause of autoimmune autonomic neuropathy (a disease which causes severe problems with the automatic functions of the body—low blood pressure, loss of sweating, salivation, and tearing, and impaired digestion). These ion channel antibodies directly affect how nerve cells function.
In addition to myasthenia and autonomic neuropathy, ion channel autoimmunity appears to be important in other neurological disorders as well, including ataxia, seizures, memory disorders, and others. The laboratory research over the next few years will focus on characterizing several forms of ion channel autoimmunity using animal model systems in an effort to understand the immune mechanisms involved and the functional effects of antibodies on ion channel function. Furthermore, these studies of immune-mediated changes in ion channel function will improve our understanding of the role of specific ion channels in the normal nervous system and how nerve cells respond to immunological injury.
Meet the Principal Investigator
Steven Vernino, M.D., Ph.D.
Vice Chair for Education & Faculty Affairs
Professor
Endowed Title: Rex Griswold Distinguished Professorship in Multiple System Atrophy; Distinguished Teaching Professor; Dr. Bob and Jean Smith Foundation Distinguished Chair in Neuromuscular Disease Research
Department: Neurology
Lab Members
Featured Publications
Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study
Vernetti PM, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Shibao CA, Peltier A, Freeman R, Gibbons C, Goldstein DS, Low PA, Singer W, Coon EA, Miglis MG, Wenning GK, Fanciulli A, Vernino S, Betensky RA, Kaufmann H 2024 Jul 147 2440-2448Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients with Synucleinopathies
Gibbons CH, Levine T, Adler C, Bellaire B, Wang N, Stohl J, Agarwal P, Aldridge GM, Barboi A, Evidente VG, Galasko D, Geschwind MD, Gonzalez-Duarte A, Gil R, Gudesblatt M, Isaacson SH, Kaufmann H, Khemani P, Kumar R, Lamotte G, Liu AJ, McFarland NR, Miglis M, Reynolds A, Sahagian GA, Saint-Hillaire MH, Schwartzbard JB, Singer W, Soileau MJ, Vernino S, Yerstein O, Freeman R 2024 331 1298-1306Saturation mutagenesis of α-synuclein reveals monomer fold that modulates aggregation
Chlebowicz J, Russ W, Chen D, Vega A, Vernino S, White CL, Rizo J, Joachimiak LA, Diamond MI 2023 Oct 9The need for consistent clinical definitions in autonomic medicine
Vernino S 2023 Jun 33 215-216MEN2B Masquerading as Postural Orthostatic Tachycardia Syndrome
Khan G, Giacona J, Mirfakhraee S, Vernino S, Vongpatanasin W 2022 Jul 4 814-818Brachial Plexus Tolerance to Single-Session SABR in a Pig Model
Hrycushko B, van der Kogel AJ, Phillips L, Chhabra A, Folkert MR, Sayre JW, Vernino S, Hassan-Rezaeian N, Yamada Y, Timmerman R, Medin PM 2022 Feb 112 565-571Autoimmune encephalitis: Proposed recommendations for symptomatic and long-term management
Author Collaboration AE, Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer MJ, Tarawneh R, Van Mater H, Muscal E, Ruhoy I, Anziska Y, Longbrake E, Benseler S, Wang C, Apperson M, Iorio R, Simabukuro MM, Zhong N, Rüegg S, Piquet A, Kuo J, Konuskan B, Frid E, Deng J, Mitchell W, Mooneyham GL, Estiasari R, Chiba Y, Alarcio M, Blackburn K 2021 Aug 92 897-907Ganglionic Acetylcholine Receptor Antibodies in Postural Tachycardia Syndrome
Bryarly M, Raj SR, Phillips L, Hynan LS, Okamoto LE, Arnold AC, Paranjape SY, Vernino M, Black BK, Vernino S 2021 Aug 11 E397-E401Autoimmune encephalitis: Proposed best practice recommendations for diagnosis and acute management
Author Collaboration AE, Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer MJ, Tarawneh R, Van Mater H, Muscal E, Ruhoy I, Anziska Y, Longbrake E, Benseler S, Wang C, Apperson M, Iorio R, Simabukuro MM, Zhong N, Rüegg S, Piquet A, Kuo J, Konuskan B, Frid E, Deng J, Mitchell W, Mooneyham GL, Estiasari R, Chiba Y, Alarcio M, Blackburn K 2021 Jul 92 757-768Long-COVID postural tachycardia syndrome: an American Autonomic Society statement
Author Collaboration tA, Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VE, Numan M, Peltier A, Snapper H, Vernino S 2021 Jun 31 365-368Response to: Human papillomavirus (HPV) vaccine safety concerning POTS, CRPS and related conditions
Author Collaboration tA, Barboi A, Gibbons CH, Bennaroch EE, Biaggioni I, Chapleau MW, Chelimsky G, Chelimsky T, Cheshire WP, Claydon VE, Freeman R, Goldstein DS, Joyner MJ, Kaufmann H, Low PA, Norcliffe-Kaufmann L, Robertson D, Shibao CA, Singer W, Snapper H, Vernino S, Raj SR 2020 Apr 30 183-184Spinal Nerve Tolerance to Single-Session Stereotactic Ablative Radiation Therapy
Hrycushko B, van der Kogel AJ, Phillips L, Folkert MR, Sayre JW, Vernino S, Hassan-Rezaeian N, Foster RD, Yamada Y, Timmerman R, Medin PM 2019 Jul 104 845-851Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar
Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD 2019 Mar 73 1207-1228Autoimmunity in postural orthostatic tachycardia syndrome: Current understanding
Vernino S, Stiles LE 2018 Dec 215 78-82Seronegative autoimmune autonomic neuropathy: a distinct clinical entity
Golden EP, Bryarly MA, Vernino S 2018 Feb 28 115-123Faciobrachial dystonic spells: Presenting feature of autoimmune encephalopathy
Dubey D, Alqallaf A, Warnack W, Gupta P, Harvey J, Vernino S 2017 Sep 65 1149-1151Neurological autoantibody prevalence in epilepsy of unknown etiology
Dubey D, Alqallaf A, Hays R, Freeman M, Chen K, Ding K, Agostini M, Vernino S 2017 Apr 74 397-402Autoimmunity-associated autonomic failure with sympathetic denervation
Goldstein DS, Holmes C, Sullivan P, Donadio V, Isonaka R, Zhong E, Pourier B, Vernino S, Kopin IJ, Sharabi Y 2017 Feb 27 57-62The major histocompatibility complex and antibody-mediated limbic encephalitis
Stüve O, Vernino S 2017 Feb 81 181-182Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
Isaacson S, Vernino S, Ziemann A, Rowse GJ, Kalu U, White WB 2016 Oct 10 755-762Diagnostic and therapeutic strategies for management of autoimmune encephalopathies
Dubey D, Blackburn K, Greenberg B, Stuve O, Vernino S 2016 Aug 16 937-949Factors contributing to delay in diagnosis of Guillain-Barré syndrome and impact on clinical outcome
Dubey D, Kapotic M, Freeman M, Sawhney A, Rojas JC, Warnack W, Vernino S 2016 Mar 53 384-387MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing
Rounds WH, Salinas EA, Wilks TB, Levin MK, Ligocki AJ, Ionete C, Pardo CA, Vernino S, Greenberg BM, Bigwood DW, Eastman EM, Cowell LG, Monson NL 2015 Nov 572 191-197Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy
Gupta A, Harris S, Vernino S, Naina HV 2015 Aug 25 255-258Disproportionate pupillary involvement in diabetic autonomic neuropathy
Yuan D, Spaeth EB, Vernino S, Muppidi S 2014 Dec 24 305-309Effectiveness of multimodality treatment for autoimmune limbic epilepsy
Dubey D, Konikkara J, Modur PN, Agostini M, Gupta P, Shu F, Vernino S 2014 Dec 16 494-499Objective characterization of the relative afferent pupillary defect in MS
Blazek P, Davis SL, Greenberg B, Conger A, Conger D, Vernino S, Beh SC, Stuve O, Saidha S, Ratchford JN, Green A, Calabresi PA, Balcer LJ, Frohman TC, Frohman E 2012 Dec 323 193-200The spectrum of clinicopathological features in pure autonomic neuropathy
Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Koyano S, Momoo T, Yuasa H, Mitake S, Higashihara M, Kaida K, Yamamoto D, Hisahara S, Shimohama S, Nakae Y, Johkura K, Vernino S, Sobue G 2012 Oct 259 2067-2075Slowly progressive ataxia, neuropathy, and oculomotor dysfunction
Jordan JT, Samuel G, Vernino S, Muppidi S 2012 Oct 69 1366-1371Sudomotor dysfunction in autoimmune autonomic ganglionopathy: A follow-up study
Kimpinski K, Iodice V, Sandroni P, Fealey RD, Vernino S, Low PA 2012 Jun 22 131-136A unique manifestation of pupillary fatigue in autoimmune autonomic ganglionopathy
Muppidi S, Scribner M, Gibbons CH, Adams-Huet B, Spaeth EB, Vernino S 2012 May 69 644-648Progressive weakness with respiratory failure in a patient with sarcoidosis
Chaudhry P, Herndon E, Vernino S, Muppidi S 2012 Apr 69 534-537Autoimmune autonomic ganglionopathy with reversible cognitive impairment
Gibbons CH, Centi J, Vernino S, Freeman R 2012 Apr 69 461-466Clinical reasoning: A 41-year-old comatose man with absent brainstem reflexes
Beh SC, Vernino S, Warnack WR 2012 Feb 78 e42-e45Isolated neck extensor myopathy: Is it responsive to immunotherapy?
Muppidi S, Saperstein DS, Shaibani A, Nations SP, Vernino S, Wolfe GI 2010 Sep 12 26-29Slowly progressive autonomic neuropathy with antiganglionic acetylcholine receptor antibody
Koike H, Koyano S, Morozumi S, Kawagashira Y, Iijima M, Katsuno M, Hattori N, Vernino S, Sobue G 2010 May 81 586-587Progress in the management of paraneoplastic neurological disorders
Sadeghian H, Vernino S 2010 Jan 3 43-52Direct and consensual murine pupillary reflex metrics: Establishing normative values
Hussain RZ, Hopkins SC, Frohman EM, Eagar TN, Cravens PC, Greenberg BM, Vernino S, Stüve O 2009 Dec 151 164-167Sudomotor dysfunction in autoimmune autonomic ganglionopathy
Kimpinski K, Iodice V, Sandroni P, Fealey RD, Vernino S, Low PA 2009 Nov 73 1501-1506Multifocal paraneoplastic cortical encephalitis associated with myasthenia gravis and thymoma
Hammoud K, Kandimala G, Warnack W, Vernino S 2009 Nov 66 1407-1409Autoimmune autonomic ganglionopathy: Treatment by plasma exchanges and rituximab
Imrich R, Vernino S, Eldadah BA, Holmes C, Goldstein DS 2009 Aug 19 259-262Special section on autoimmune autonomic ganglionopathy. Editorial.
Vernino S 2009 Mar 146 1-2Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy
Vernino S, Hopkins S, Wang Z 2009 Mar 146 3-7Autoimmune autonomic ganglionopathy with late-onset encephalopathy
Baker SK, Morillo C, Vernino S 2009 Mar 146 29-32Antibody testing as a diagnostic tool in autonomic disorders.
Vernino S 2009 Feb 19 13-19Paraneoplastic disorders affecting the neuromuscular junction or anterior horn cell
Vernino S 2009 Feb 15 132-146Prevalence and mechanism of bladder dysfunction in Guillain-Barré syndrome
Sakakibara R, Uchiyama T, Kuwabara S, Mori M, Ito T, Yamamoto T, Awa Y, Yamaguchi C, Yuki N, Vernino S, Kishi M, Shirai K 2009 28 432-437Characterization of ganglionic acetylcholine receptor autoantibodies
Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA 2008 Jun 197 63-69Invited Article: Autonomic ganglia: Target and novel therapeutic tool
Vernino S, Sandroni P, Singer W, Low PA 2008 May 70 1926-1932Propofol for stiff-person syndrome: Learning new tricks from an old dog
Vernino S, McEvoy K 2008 Apr 70 1584-1585Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease
Briani C, Doria A, Ruggero S, Toffanin E, Luca M, Albergoni MP, D'Odorico A, Grassivaro F, Lucchetta M, De Lazzari F, Balzani I, Battistin L, Vernino S 2008 Feb 41 100-104Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy
Gibbons CH, Vernino SA, Freeman R 2008 Feb 65 213-217Chapter 14 Peripheral nerve hyperexcitability and the neuromuscular junction
Vernino S 2008 91 433-443Dysfunction of the pupillary light reflex in experimental autoimmune autonomic ganglionopathy
Mukherjee S, Vernino S 2007 Dec 137 19-26EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil
O'Neill BP, Vernino S, Dogan A, Giannini C 2007 Jul 9 364-369Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current
Wang Z, Low PA, Jordan J, Freeman R, Gibbons CH, Schroeder C, Sandroni P, Vernino S 2007 May 68 1917-1921Postural orthostatic tachycardia syndrome: The Mayo Clinic experience
Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, Lennon VA, Shen WK, Low PA 2007 Mar 82 308-313Steroid-responsive encephalopathy associated with autoimmune thyroiditis
Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B 2006 Feb 63 197-202L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy
Gibbons CH, Vernino SA, Kaufmann H, Freeman R 2005 Oct 65 1104-1106Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil
Vernino S, Salomao DR, Habermann TM, O'Neill BP 2005 Aug 65 639-641Speech and language findings associated with paraneoplastic cerebellar degeneration
Paslawski T, Duffy JR, Vernino S 2005 Aug 14 200-207Autoantibody profiles and neurological correlations of thymoma
Vernino S, Lennon VA 2004 Nov 10 7270-7275From parallel to perpendicular: Getting "straightened out" with levodopa therapy [2]
Glynn SM, Pittock SJ, Vernino SA 2004 Jun 79 828-829Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S 2004 Apr 62 1177-1182Immunomodulatory treatment trial for paraneoplastic neurological disorders
Vernino S, O'Neill BP, Marks RS, O'Fallon JR, Kimmel DW 2004 Jan 6 55-62Myasthenia gravis, thymoma, and intestinal pseudo-obstruction
Rakocevic G, Barohn R, McVey AL, Damjanov I, Morte PD, Vernino S, Lennon V 2003 Dec 5 93-95Cause-specific mortality after first cerebral infarction: A population-based study
Vernino S, Brown RD, Sejvar JJ, Sicks JD, Petty GW, O'Fallon MW 2003 Aug 34 1828-1832Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies
Oh SJ, Alapati A, Claussen GC, Vernino S 2003 Jun 27 757-760Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease
Lennon VA, Ermilov LG, Szurszewski JH, Vernino S 2003 Mar 111 907-913Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease
Lennon VA, Ermilov LG, Szurszewski JH, Vernino S 2003 Mar 111 907-913Muscle and neuronal autoantibody markers of thymoma: Neurological correlations
Vernino S, Lennon VA 2003 998 359-361Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma
Vernino S, Eggenberger ER, Rogers LR, Lennon VA 2002 Sep 59 929-932Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma
Vernino S, Tuite P, Adler CH, Meschia JF, Boeve BF, Boasberg P, Parisi JE, Lennon VA 2002 51 625-630Persistent facial myokymia associated with K+ channel antibodies
Gutmann L, Tellers JG, Vernino S 2001 Nov 57 1707-1708Paraneoplastic and metastatic neurologic complications of Merkel cell carcinoma
Eggers SD, Salomao DR, Dinapoli RP, Vernino S 2001 76 327-330ANNA-3 anti-neuronal nuclear antibody: Marker of lung cancer-related autoimmunity
Chan KH, Vernino S, Lennon VA 2001 50 301-311Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neukopathies
Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA 2000 Sep 343 847-855New Purkinje cell antibody (PCA-2): Marker of lung cancer-related neurological autoimmunity
Vernino S, Lennon VA 2000 47 297-305Fulminant autoimmune cortical encephalitis associated with thymoma treated with plasma exchange
Rickman OB, Parisi JE, Yu Z, Lennon VA, Vernino S 2000 75 1321-1326Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability
Vernino S, Auger RG, Emslie-Smith AM, Harper CM, Lennon VA 1999 Oct 53 1233-1239Coma in fulminant pneumococcal meningitis: New MRI observations
Vernino S, Wijdicks EF, McGough PF 1998 Oct 51 1200-1202Postpartum thrombotic thrombocytopenic purpura complicated by Budd-Chiari syndrome
Hsu HW, Belfort MA, Vernino S, Moake JL, Moise KJ 1995 85 839-843Functional diversity of neuronal nicotinic acetylcholine receptors
Patrick J, Sequela P, Vernino S, Amador M, Luetje C, Dani JA 1993 Jan 98 113-120Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors
Vernino S, Amador M, Luetje CW, Patrick J, Dani JA 1992 Jan 8 127-134Contact Us
Steven Vernino, M.D., Ph.D.
Professor of Neurology
Phone: 214-648-8816
Fax: 214-648-9129
Lab: 214-648-9275
Mailing Address
5323 Harry Hines Boulevard
Dallas, Texas 75390-8869
Join Our Lab
Reach out to us below to learn more about opportunities with Vernino Lab.